These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 23573256

  • 1. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.
    Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M.
    PLoS One; 2013; 8(4):e60442. PubMed ID: 23573256
    [Abstract] [Full Text] [Related]

  • 2. Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52.
    Yamasaki Y, Satoh M, Mizushima M, Okazaki T, Nagafuchi H, Ooka S, Shibata T, Nakano H, Ogawa H, Azuma K, Maeda A, Tonooka K, Ito H, Takakuwa Y, Inoue M, Mitomi H, Kiyokawa T, Tsuchida K, Matsushita H, Mikage H, Murakami Y, Chan JY, Ozaki S, Yamada H.
    Mod Rheumatol; 2016; 26(3):403-9. PubMed ID: 26344678
    [Abstract] [Full Text] [Related]

  • 3. Clinical characteristics of interstitial lung diseases positive to different anti-synthetase antibodies.
    Jiang M, Dong X, Zheng Y.
    Medicine (Baltimore); 2021 May 14; 100(19):e25816. PubMed ID: 34106621
    [Abstract] [Full Text] [Related]

  • 4. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y, Ye Q.
    BMC Pulm Med; 2021 Feb 12; 21(1):57. PubMed ID: 33579248
    [Abstract] [Full Text] [Related]

  • 5. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis.
    Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, Lyons R, Loy AC, Chan EK, Reeves WH, Satoh M.
    Arthritis Rheum; 2006 Jun 12; 54(6):2004-9. PubMed ID: 16732549
    [Abstract] [Full Text] [Related]

  • 6. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, Enomoto N, Inui N, Nakamura Y, Hosono Y, Imura Y, Mimori T, Suda T.
    Respir Med; 2016 Dec 12; 121():91-99. PubMed ID: 27888997
    [Abstract] [Full Text] [Related]

  • 7. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis.
    Matsushita T, Hasegawa M, Fujimoto M, Hamaguchi Y, Komura K, Hirano T, Horikawa M, Kondo M, Orito H, Kaji K, Saito Y, Matsushita Y, Kawara S, Yasui M, Seishima M, Ozaki S, Kuwana M, Ogawa F, Sato S, Takehara K.
    J Rheumatol; 2007 May 12; 34(5):1012-8. PubMed ID: 17309126
    [Abstract] [Full Text] [Related]

  • 8. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
    Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, Usui T, Tanaka M, Nagai S, Umehara H, Mimori T.
    Autoimmunity; 2006 May 12; 39(3):233-41. PubMed ID: 16769657
    [Abstract] [Full Text] [Related]

  • 9. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Taguchi Y, Hatta K, Noma S, Kobashi Y, Yoshizawa A, Oga T, Hirai T, Chin K, Nagai S, Izumi T, Mimori T, Mishima M.
    Respir Med; 2017 Jun 12; 127():57-64. PubMed ID: 28461123
    [Abstract] [Full Text] [Related]

  • 10. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.
    Fukamatsu H, Hirai Y, Miyake T, Kaji T, Morizane S, Yokoyama E, Hamada T, Oono T, Koyama Y, Norikane S, Iwatsuki K.
    J Dermatol; 2019 Oct 12; 46(10):886-897. PubMed ID: 31418479
    [Abstract] [Full Text] [Related]

  • 11. Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies.
    Koreeda Y, Higashimoto I, Yamamoto M, Takahashi M, Kaji K, Fujimoto M, Kuwana M, Fukuda Y.
    Intern Med; 2010 Oct 12; 49(5):361-9. PubMed ID: 20190466
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China.
    Wang R, Zhao Y, Qi F, Wu X, Wang Y, Xu Y, Wu Y, Zhang N, Hou H, Sun W, Li X, Wei W.
    Clin Rheumatol; 2023 Mar 12; 42(3):703-709. PubMed ID: 36308573
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
    Hozumi H, Fujisawa T, Nakashima R, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Inui N, Nakamura Y, Mimori T, Suda T.
    J Rheumatol; 2019 May 12; 46(5):509-517. PubMed ID: 30647164
    [Abstract] [Full Text] [Related]

  • 14. Comparison of cytokine profiles between anti-ARS antibody-positive interstitial lung diseases and those with anti-MDA-5 antibodies.
    Asakawa K, Yoshizawa K, Aoki A, Kimura Y, Tanaka T, Ohashi K, Hayashi M, Kikuchi T, Sato S, Takada T.
    Clin Rheumatol; 2020 Jul 12; 39(7):2171-2178. PubMed ID: 32056068
    [Abstract] [Full Text] [Related]

  • 15. [Reliability and clinical utility of Enzyme-linked immunosorbent assay for detection of anti-aminoacyl-tRNA synthetase antibody].
    Abe T, Tsunoda S, Nishioka A, Azuma K, Tsuboi K, Ogita C, Yokoyama Y, Furukawa T, Maruoka M, Tamura M, Yoshikawa T, Saito A, Sekiguchi M, Azuma N, Kitano M, Matsui K, Hosono Y, Nakashima R, Ohmura K, Mimori T, Sano H.
    Nihon Rinsho Meneki Gakkai Kaishi; 2016 Jul 12; 39(2):140-4. PubMed ID: 27212600
    [Abstract] [Full Text] [Related]

  • 16. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ.
    Intern Med J; 2011 Sep 12; 41(9):674-9. PubMed ID: 20059602
    [Abstract] [Full Text] [Related]

  • 17. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
    Xie MM, Zou RY, Li Y, Liu Y, Chen LL, Liu XQ, Zhao Q, Ding JJ, Chen ZY, Cai HR.
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct 12; 42(10):765-770. PubMed ID: 31594111
    [Abstract] [Full Text] [Related]

  • 18. Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
    Yoshida N, Okamoto M, Kaieda S, Fujimoto K, Ebata T, Tajiri M, Nakamura M, Tominaga M, Wakasugi D, Kawayama T, Kuwana M, Mimori T, Ida H, Hoshino T.
    Respir Investig; 2017 Jan 12; 55(1):24-32. PubMed ID: 28012490
    [Abstract] [Full Text] [Related]

  • 19. The clinical features and prognoses of anti-MDA5 and anti-aminoacyl-tRNA synthetase antibody double-positive dermatomyositis patients.
    Chen X, Zhang L, Jin Q, Lu X, Lei J, Peng Q, Wang G, Ge Y.
    Front Immunol; 2022 Jan 12; 13():987841. PubMed ID: 36110863
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics of patients with anti-aminoacyl-tRNA synthetase antibody positive idiopathic interstitial pneumonia.
    Yura H, Sakamoto N, Satoh M, Ishimoto H, Hanaka T, Ito C, Hasegawa T, Tanaka S, Miyamura T, Nakashima S, Hara A, Kakugawa T, Oda K, Kido T, Obase Y, Ishimatsu Y, Yatera K, Kawakami A, Mukae H.
    Respir Med; 2017 Nov 12; 132():189-194. PubMed ID: 29229096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.